HIV/AIDS
Report summarizes HIV/AIDS study findings from University of Connecticut
Published in AIDS Weekly, January 28th, 2008
According to a study from the United States, "It has become crucial for risk reduction interventions targeting injection drug users (IDUs) in treatment to be '' community-friendly '' and potent over time so that limited resources may be optimally utilized. This study examined (1) the extent to which observed post-intervention effects-including enhanced HIV-related knowledge, motivation, behavioral skills, and drug- and sex-risk reduction behavior-decayed over time and (2) whether repeating the intervention at follow-up provided additional benefit."
"Approximately 10 months after completing an adapted, substantially shortened, version of an evidence-based intervention,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-01-28)
More Articles from AIDS Weekly
- HIV/AIDS
HIV shifting from most to least educated in sub-Saharan Africa - HIV/AIDS
Keeping young South Africans in school: A 'social vaccine' against AIDS - HIV/AIDS
Uncovering the Achilles' heel of the HIV-1 envelope - HIV/AIDS
Research from J.A. Pineda and colleagues provide new insights into HIV/AIDS - HIV/AIDS
Research from University of California has provided new data on HIV/AIDS - HIV/AIDS
Studies from University of California, Medical Department provide new data on HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
